BreezeBio
PrivateLast Round
Series B
Feb 25, 2026
Total Funding Raised
$153.55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BreezeBio is a biotechnology company that develops precision genetic medicines for autoimmune diseases and oncology using its proprietary NanoGalaxy nanoparticle delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BreezeBio Comparables
Compare BreezeBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Code Biotherapeutics | 88% | |
| ViaNautis Bio | 84% | |
| Hopewell Therapeutics | 82% | |
BreezeBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 25, 2026 | ||||
| Series B | Nov 20, 2024 | ||||
| Series A Extension | Jan 23, 2024 | ||||
| Grant | Dec 13, 2023 | ||||
| Series A | Sep 23, 2021 | ||||
Seed | Dec 11, 2018 |
Key People
Founding team and executive leadership
BreezeBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series B |
| DSC Investment | Series B |
| Top Harvest Capital | Series B |
| K2 Investment Partners | Series A Extension |
| IMM Investment | Series A, Series A Extension |
| KB Investment | Series A, Series A Extension |
| DAYLI Partners | Series A Extension, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Focus on IND-enabling studies for genetic medicine delivery platform.
- Feb 25, 2026
$60M round led by DSC Investment and Yuanta Investment.
BreezeBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BreezeBio's valuation, stock price, and market status.